<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Digital Pathology News | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Wed, 15 Jul 2026 12:28:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Digital Pathology News | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Indica Labs: HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability</title>
		<link>https://tissuepathology.com/2026/07/15/indica-labs-halo-ap-2-5-advances-digital-pathology-with-enhanced-automation-collaboration-and-scalability/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 15 Jul 2026 12:28:27 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Indica Labs: HALO AP 2.5]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Software]]></category>
		<category><![CDATA[workflow]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24553</guid>

					<description><![CDATA[<p>Albuquerque, NM, July 14th, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced a new software release designed to streamline and scale digital pathology workflows through enhanced automation, collaboration, and system transparency. “Clinical laboratories need digital pathology systems that can adapt to the way their teams actually work,” said Hallie [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/15/indica-labs-halo-ap-2-5-advances-digital-pathology-with-enhanced-automation-collaboration-and-scalability/">Indica Labs: HALO AP 2.5 Advances Digital Pathology with Enhanced Automation, Collaboration, and Scalability</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Techcyte Announces Go-Live of Fusion Parasitology Suite at Sonora Quest Laboratories</title>
		<link>https://tissuepathology.com/2026/07/14/techcyte-announces-go-live-of-fusion-parasitology-suite-at-sonora-quest-laboratories/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 14 Jul 2026 12:12:09 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Banner Health]]></category>
		<category><![CDATA[parasitology]]></category>
		<category><![CDATA[Quest Diagnostics]]></category>
		<category><![CDATA[Sonora Quest Laboratories]]></category>
		<category><![CDATA[Techcyte]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24551</guid>

					<description><![CDATA[<p>OREM, UT, UNITED STATES, July 13, 2026 /EINPresswire.com/ &#8212; Techcyte today announced that Sonora Quest Laboratories, one of the largest integrated laboratory systems in the United States, has gone live with the Techcyte Fusion® Parasitology Suite (for research use only). As a joint venture between Banner Health and Quest Diagnostics, Sonora Quest Laboratories plays a key role in delivering [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/14/techcyte-announces-go-live-of-fusion-parasitology-suite-at-sonora-quest-laboratories/">Techcyte Announces Go-Live of Fusion Parasitology Suite at Sonora Quest Laboratories</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Join Proscia for Webinar</title>
		<link>https://tissuepathology.com/2026/07/13/join-proscia-for-webinar/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 13 Jul 2026 11:23:49 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Webinars]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[webinar]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24548</guid>

					<description><![CDATA[<p>From Proscia: Meet the Next Generation of Concentriq: Pathology’s AI Platform for Precision Medicine Product Webinar July 28, 2026 &#124; 12pm ET Register Now Diagnostic labs are being asked to do more than ever: growing workloads, increasingly case complexity, and not enough pathologists to go around. The old playbook, a pathology platform with AI bolted [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/13/join-proscia-for-webinar/">Join Proscia for Webinar</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology</title>
		<link>https://tissuepathology.com/2026/07/10/lumito-and-navinci-initiate-pilot-project-promising-initial-results-from-evaluation-of-combined-technology/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 10 Jul 2026 12:29:58 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lumito]]></category>
		<category><![CDATA[Navinci Diagnostics]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[pilot project]]></category>
		<category><![CDATA[tissue analysis]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24545</guid>

					<description><![CDATA[<p>July 9, 2026 &#8211; Lumito AB (publ) (&#8220;Lumito&#8221; or the &#8220;Company&#8221;) today announces that the Company has initiated a pilot project together with the Swedish biotech company Navinci Diagnostics AB (”Navinci”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/10/lumito-and-navinci-initiate-pilot-project-promising-initial-results-from-evaluation-of-combined-technology/">Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>CorePlus Integrates AI-Powered Prostate Cancer Risk Stratification Tool into its Digital Pathology Diagnostic Pathway — a First in Puerto Rico</title>
		<link>https://tissuepathology.com/2026/07/09/coreplus-integrates-ai-powered-prostate-cancer-risk-stratification-tool-into-its-digital-pathology-diagnostic-pathway-a-first-in-puerto-rico/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 09 Jul 2026 12:41:46 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[CorePlus]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[prostate cancer]]></category>
		<category><![CDATA[Puerto Rico]]></category>
		<category><![CDATA[Risk Stratification]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24540</guid>

					<description><![CDATA[<p>SAN JUAN, Puerto Rico&#8211;(BUSINESS WIRE)&#8211;CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first laboratory in Puerto Rico to bring this guideline-recommended AI test into routine clinical use, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate Test [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/09/coreplus-integrates-ai-powered-prostate-cancer-risk-stratification-tool-into-its-digital-pathology-diagnostic-pathway-a-first-in-puerto-rico/">CorePlus Integrates AI-Powered Prostate Cancer Risk Stratification Tool into its Digital Pathology Diagnostic Pathway — a First in Puerto Rico</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC</title>
		<link>https://tissuepathology.com/2026/07/08/agenus-and-noetik-present-asco-2026-data-linking-ai-analysis-of-routine-pretreatment-tumor-pathology-images-to-response-and-survival-with-botbal-in-mss-metastatic-crc/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 08 Jul 2026 12:15:19 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Agenus]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[ASCO 2026]]></category>
		<category><![CDATA[BOT+BAL]]></category>
		<category><![CDATA[botensilimab + balstilimab]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[MSS Metastatic CRC]]></category>
		<category><![CDATA[Noetik]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24536</guid>

					<description><![CDATA[<p>Agenus and Noetik: Noetik’s TARIO-2 platform analyzed routine pretreatment H&#38;E images from 113 BOT+BAL-treated patients and identified spatial tumor microenvironment patterns associated with response and survival In a retrospective analysis of refractory MSS metastatic colorectal cancer without active liver metastases, the AI-identified subgroup had a 64% response rate to BOT+BAL, compared with 9% in the [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/07/08/agenus-and-noetik-present-asco-2026-data-linking-ai-analysis-of-routine-pretreatment-tumor-pathology-images-to-response-and-survival-with-botbal-in-mss-metastatic-crc/">Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
